Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

The Korean Society of Haematology AML/MDS Working Party

doi:10.1111/bjh.15991

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

The Korean Society of Haematology AML/MDS Working Party

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e151-e155
Journal	British Journal of Haematology
Volume	186
Issue number	5
DOIs	https://doi.org/10.1111/bjh.15991
Publication status	Published - 2019

Keywords

Hypomethylating agent
MDS
lenalidomide

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.15991

Cite this

@article{7f4c9db45e7046c5937cda5031a8ca53,

title = "Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome",

keywords = "Hypomethylating agent, MDS, lenalidomide",

author = "{The Korean Society of Haematology AML/MDS Working Party} and Hawk Kim and Lee, {Je Hwan} and Lee, {Won Sik} and Inho Kim and Moon, {Joon Ho} and Choi, {Chul Won} and Lee, {Ho Sup} and Jinny Park and Yunsuk Choi and Shin, {Ho Jin} and Cho, {Su Hee} and Kim, {Kyoung Ha} and Kim, {Sung Yong} and Kim, {Yoo Jin}",

year = "2019",

doi = "10.1111/bjh.15991",

language = "English",

volume = "186",

pages = "e151--e155",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

AU - The Korean Society of Haematology AML/MDS Working Party

AU - Kim, Hawk

AU - Lee, Je Hwan

AU - Lee, Won Sik

AU - Kim, Inho

AU - Moon, Joon Ho

AU - Choi, Chul Won

AU - Lee, Ho Sup

AU - Park, Jinny

AU - Choi, Yunsuk

AU - Shin, Ho Jin

AU - Cho, Su Hee

AU - Kim, Kyoung Ha

AU - Kim, Sung Yong

AU - Kim, Yoo Jin

PY - 2019

Y1 - 2019

KW - Hypomethylating agent

KW - MDS

KW - lenalidomide

UR - http://www.scopus.com/inward/record.url?scp=85067381860&partnerID=8YFLogxK

U2 - 10.1111/bjh.15991

DO - 10.1111/bjh.15991

M3 - Letter

C2 - 31177524

AN - SCOPUS:85067381860

SN - 0007-1048

VL - 186

SP - e151-e155

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this